C2-ceramide and C6-ceramide inhibited priming for enhanced release of superoxide in monocytes, but had no effect on the killing of leukaemic cells by monocytes

Immunology

Volumn 90, Issue 4, 1997, Pages 477-482

  Nakabo, Y ^a   Pabst, M J ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; INTERLEUKIN 1BETA; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; DRUG DERIVATIVE; GAMMA INTERFERON; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; N ACETYLSPHINGOSINE; N CAPROYLSPHINGOSINE; N-ACETYLSPHINGOSINE; N-CAPROYLSPHINGOSINE; SPHINGOSINE;

ADULT; ARTICLE; CELL LINE; CYTOTOXICITY; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BIOSYNTHESIS; BLOOD; CELL CULTURE; DRUG EFFECT; IMMUNOLOGY; LEUKEMIA; METABOLISM;

CERAMIDES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; LEUKEMIA; LIPOPOLYSACCHARIDES; MONOCYTES; SPHINGOSINE; SUPEROXIDES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030612796     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.d01-2189.x     Document Type: Article

References (27)

1. FIDLER I.J. & SCHROIT A.J. (1988) Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim Biophys Acta 948, 151.
2. SASADA M. & JOHNSTON R.B., JR. (1980) Macrophage microbicidal activity: correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J Exp Med 152, 85.
3. KOFF W.C., FIDLER I.J., SHOWALTER S.D. et al. (1984) Human monocytes activated by immunomodulators in liposomes lyse herpes virus-infected but not normal cells. Science 224, 1007.
4. NATHAN C.F., MURRAY H.W., WIEBE M.E. & RUBIN B.Y. (1983) Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158, 670.
5. PABST M.J. & JOHNSTON R.B., JR. (1980) Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J Exp Med 151, 101.
6. AIDA Y. & PABST M.J. (1990) Priming of neutrophils by lipopolysaccharide for enhanced release of superoxide. Requirement for plasma but not for tumor necrosis factor-α. J Immunol 145, 3017.
7. WORTHEN G.S., SECCOMBE J.F., CLAY K.L., GUTHRIE L.A. & JOHNSTON R.B., JR. (1988) The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion. J Immunol 140, 3553.
8. GORECKA-TISERA A.M., SNOWDOWNE K.W. & BORLE A.B. (1986) Implications of a rise in cytosolic free calcium in the activation of RAW-264 macrophages for tumor cell killing. Cell Immunol 100, 411.
9. BRAUN D.P., AHN M.-C., HARRIS J.E. et al. (1993) Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patients to modulation of arachidonic acid metabolism. Cancer Res 53, 3362.
10. NOVOTNEY M., CHANG Z.-L., UCHIYAMA H. & SUZUKI T. (1991) Protein kinase C in tumoricidal activation of mouse macrophage cell lines. Biochemistry 30, 5597.
11. WEINSTEIN S.L., GOLD M.R. & DEFRANCO A.L. (1991) Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc Natl Acad Sci USA 88, 4148.
12. MANTHEY C.L., BRANDES M.E., PERERA P.-Y. & VOGEL S.N. (1992) Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J Immunol 149, 2459.
13. MEGYERI P., PABST K.M. & PABST M.J. (1995) Serine protease inhibitors block priming of monocytes for enhanced release of superoxide. Immunology 86, 629.
14. NAKABO Y. & PABST M.J. (1996) Lysis of leukemic cells by human macrophages: inhibition by 4-(2-aminoethyl)-benzenesulfonyl fluoride (AEBSF), a serine protease inhibitor. J Leukoc Biol 60, 328.
15. KOLESNICK R. & GOLDE D.W. (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77, 325.
16. WRIGHT S.D. & KOLESNICK R.N. (1995) Does endotoxin stimulate cells by mimicking ceramide? Immunol Today 16, 297.
17. d) macrophages. J Immunol 155, 2303.
18. NAKAMURA T., ABE A., BALAZOVICH K.J. et al. (1994) Ceramide regulates oxidant release in adherent human neutrophils. J Biol Chem 269, 18384.
19. 2-ceramide) inhibited neutrophil superoxide formation and calcium influx. J Biol Chem 270, 3056.
20. DOBROWSKY R.T., KAMIBAYASHI C., MUMBY M.C. & HANNUN Y.A. (1993) Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 268, 15523.
21. HANNUN Y.A. & BELL R.M. (1987) Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 235, 670.
22. HANNUN Y.A., OBEID L.M. & WOLFF R.A. (1993) The novel second messenger ceramide: identification, mechanism of action, and cellular activity. Adv Lipid Res 25, 43.
23. FOREHAND J.R., PABST M.J., PHILLIPS W.A. & JOHNSTON R.B., JR. (1989) Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst: role of intracellular free calcium. J Clin Invest 83, 74.
24. OBEID L.M., LINARDIC C.M., KAROLAK L.A. & HANNUN Y.A. (1993) Programmed cell death induced by ceramide. Science 259, 1769.
25. MANGAN D.F., ROBERTSON B. & WAHL S.M. (1992) IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol 148, 1812.
26. GOLENBOOCK D.T., HAMPTON R.Y., QURESHI N., TAKAYAMA K. & RAETZ C.R.H. (1991) Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 266, 19490.
27. AIDA Y., KUSUMOTO K., NAKATOMI K., TAKADA H., PABST M.J. & MAEDA K. (1995) An analogue of lipid A and LPS from Rhodobacter sphaeroides inhibit neutrophil responses to LPS by blocking receptor recognition of LPS and by depleting LPS-binding protein in plasma. J Leukoc Biol 58, 675.